Placebo - Cap

DRUG18 trials

Conditions

AddictionAlcohol Use DisorderAtopic DermatitisDeliriumDepressive Disorder, MajorEndometriosisGastroesophageal RefluxHaloperidol

Phase 1

INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers

CompletedNCT02989662

Johns Hopkins UniversityAlcohol Use Disorder

Start: 2017-09-26End: 2024-01-31Updated: 2025-05-30

A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.

WithdrawnNCT03752294

University of Rhode IslandMild Alzheimer's Disease, Mild Cognitive Impairment

Start: 2019-05-31End: 2022-05-31Updated: 2025-04-17

Pharmacological Modulation of Belief Salience

CompletedNCT03754062

King's College LondonHaloperidol, L-DOPA, Placebo

Start: 2017-06-01End: 2019-09-01Updated: 2019-10-10

Phase 2

A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia

CompletedNCT02969382

Otsuka Pharmaceutical Development & Commercialization, Inc.Schizophrenia

Start: 2016-12-05End: 2018-07-31Updated: 2024-07-05

Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer

TerminatedNCT03010761

China Medical University HospitalAddiction

Start: 2016-01-14End: 2018-01-31Updated: 2019-07-24

OPTIMA-TBI Pilot Study

TerminatedNCT03345550

University of MichiganMild Traumatic Brain Injury

Start: 2017-09-12End: 2021-07-27Updated: 2023-05-23

NMDA Modulation in Major Depressive Disorder in Late- Life

CompletedNCT03414931

Chang Gung Memorial HospitalDepressive Disorder, Major

Start: 2016-01-31End: 2020-11-30Updated: 2020-12-01

Fexofenadine Use in Gastroesophageal Reflux Symptoms

TerminatedNCT03425097

Stanford UniversityGastroesophageal Reflux

Start: 2018-02-07End: 2019-01-08Updated: 2021-02-17

ENAC Blockade and Arterial Stiffness

CompletedNCT03837626

University of Missouri-ColumbiaInsulin Resistance, Overweight and Obesity

Start: 2019-07-15End: 2025-04-30Updated: 2025-12-30

Cabergoline for the Treatment of Chronic Pain Due to Endometriosis

CompletedNCT03928288

Boston Children's HospitalEndometriosis

Start: 2019-12-02End: 2026-01-14Updated: 2026-01-28

Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function

CompletedNCT03933618

Albany Medical CollegeHypogonadism, Male

Start: 2015-04-02End: 2017-03-08Updated: 2019-11-18

Phase 3

Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis

CompletedNCT03047954

Vifor PharmaAtopic Dermatitis

Start: 2003-07-31End: 2006-12-31Updated: 2017-02-09

Evening Primrose Oil Efficacy in Second Trimester Abortion

NCT03698734

Ain Shams UniversityMissed Abortion

Start: 2018-11-01End: 2019-11-01Target: 100Updated: 2018-10-09

Phase 4

Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension

CompletedNCT03006471

University of GuadalajaraPreDiabetes, Prehypertension

Start: 2016-03-30End: 2018-06-29Updated: 2020-11-09

Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension

NCT03592667

University of GuadalajaraHypertension

Start: 2019-02-14End: 2021-07-31Target: 20Updated: 2020-12-28

Modulating the Vaginal Microbiome After Implantation Failure

CompletedNCT03843112

Zealand University HospitalImplantation Failure, Infertility, Female, Vaginal Flora Imbalance

Start: 2019-03-01End: 2021-02-27Updated: 2021-03-23

The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU

CompletedNCT03931070

Rhode Island HospitalDelirium

Start: 2019-05-09End: 2022-02-01Updated: 2024-04-10

Unknown Phase

Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis

CompletedNCT03527680

nooshin daliliHemodialysis Complication

Start: 2016-09-01End: 2016-12-30Updated: 2018-05-17

Frontiers in Endocrinology2022-12-0129 citations

O-024 Does a vaginal lactobacilli probiotic treatment improve an unfavourable vaginal microbiome before fertility treatment? A randomised, double-blinded, placebo-controlled trial

Human Reproduction2022-06-29

Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial

The International Journal of Neuropsychopharmacology2022-01-1139 citations

Assessment of Negative Symptoms in Clinical Trials of Acute Schizophrenia: Test of a Novel Enrichment Strategy

Schizophrenia Bulletin Open2022-01-018 citations

Depicting Safety Profile of TAAR1 Agonist Ulotaront Relative to Reactions Anticipated for a Dopamine D2-Based Pharmacological Class in FAERS.

2021-11-0917 citations

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

New England Journal of Medicine2020-04-15276 citations

138 Efficacy and Safety of SEP-363856, a Novel Psychotropic Agent with a Non-D2 Mechanism of Action, in the Treatment of Schizophrenia

CNS Spectrums2020-04-016 citations